Iterum Therapeutics plc (ITRM) Made Misleading Statements Regarding its Drug Candidate     Iterum is developing sulopenem, an anti-infective compound with oral and intravenous formulations that is in Phase III clinical

Yalla Group Limited (YALA) Overstated its User Metrics and Revenue      Yalla Group Limited held its U.S. initial public offering (“IPO”) on September 29, 2020.   The Registration Statement in support

Katapult Holdings, Inc. (KPLT) Failed to Disclose Declining E-commerce Retail Sales and Consumer Spending        FinServe, a special purpose acquisition company, entered into a definitive merger agreement with Katapult to

CorMedix Inc. (CRMD) Failed to Disclose Deficiencies in the Manufacturing Process of its Lead Product Candidate CorMedix completed submission of a New Drug Application (“NDA”) to the U.S. Food and

Ardelyx Inc. (ARDX) Made Misleading Statements in its Registration Statement in Connection with its Initial Public Offering   Defendants submitted a New Drug Application (NDA) to the U.S. Food and

Live Ventures Inc. (LIVE) Made Misleading Statements Regarding its Business, Operations, and Prospects     During the class period, defendants made materially false and misleading statements and failed to disclose a

Concho Resources Inc. (CXO) Misled the Investing Public Regarding Optimum Well Spacing and its Ability to Take on Large-Scale Projects   In 2018, Concho constructed the Dominator Project in the

BlueCity Holdings Limited (BLCT) Misled Investors Regarding the Company’s Capability for Sustainable Growth   BlueCity conducted its IPO on July 8, 2020, issuing 5.3 million shares of the Company’s ADSs

PayPal Holdings, Inc. (PYPL) is Being Investigated by the SEC and Consumer Financial Protection Bureau PayPal executives hid the fact that its business, operations, and compliance policies were not in